Featured Research

from universities, journals, and other organizations

Doctors to treat septic patients with hypothermia

Date:
July 6, 2010
Source:
Society for Experimental Biology
Summary:
Mild hypothermia can reduce the effects of sepsis on oxygen transport around the body and may be a valuable tool in the treatment of human sepsis patients. Sepsis is an inflammatory response to infection and will often result in septic shock, which is the biggest cause of death in intensive care units.

Inducing mild hypothermia is easy to implement in clinical practice and may be a valuable tool in the treatment of human sepsis patients, say researchers at the University of Brest, France.

Sepsis is an inflammatory response to infection and will often result in septic shock, which is the biggest cause of death in intensive care units.

New research shows that the development of sepsis in rats living under hypothermic conditions was slower than in normal conditions and they survived much longer.

The research is presented on Thursday 1st July at the Society for Experimental Biology Annual Meeting in Prague.

The new research showed that rats with sepsis living under normal conditions (38 ēC) showed a decreased ability to carry oxygen via the blood from the lungs to vital organs around the body, compared to those living under mildly hypothermic conditions (34 ēC).

Hypothermia could have a beneficial effect in septic patients whose uptake of oxygen has been affected by the condition, by increasing the ability of the pigment in red-blood cells (haemoglobin, Hb) to carry oxygen, thus balancing the harmful effects of sepsis, say the researchers.

Under normal conditions, sepsis can lead to septic shock, causing multiple organ dysfunction and death in 60% of cases.

Building on these results, the research team are carrying out a pilot clinical study into the efficiency, safety and practicality of using mild hypothermia as a treatment for septic shock in humans.

The pilot study is being carried out Professor Erwan L'Her from Brest hospital and colleagues from the ORPHY laboratory in the University of Brest.

"The preliminary results suggest that mild hypothermia is safe and easily induced in septic shock patients and no serious adverse effects were observed," explained Karelle Leon, who is carrying out the research.

Hypothermia is already frequently induced in human patients in hospital to protect the brain from further damage after an injury has been sustained.


Story Source:

The above story is based on materials provided by Society for Experimental Biology. Note: Materials may be edited for content and length.


Cite This Page:

Society for Experimental Biology. "Doctors to treat septic patients with hypothermia." ScienceDaily. ScienceDaily, 6 July 2010. <www.sciencedaily.com/releases/2010/06/100630213612.htm>.
Society for Experimental Biology. (2010, July 6). Doctors to treat septic patients with hypothermia. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2010/06/100630213612.htm
Society for Experimental Biology. "Doctors to treat septic patients with hypothermia." ScienceDaily. www.sciencedaily.com/releases/2010/06/100630213612.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) — Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) — Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) — Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins